Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

Group 1 - The article discusses the investment insights and strategies of a writer focused on Long/Short investment ideas in North America [1] - The writer has a background in finance and economics, holding a Master's degree from Queen Mary University of London and a Bachelor's degree from Middlesex University [1] Group 2 - The article does not provide specific company or industry analysis, nor does it include any financial data or performance metrics [2][3]